GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for terminal nucleotidyltransferase 5A (Q96IP4)

Analyse AlphaFold monomer V2.0 prediction for terminal nucleotidyltransferase 5A… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q96IP4
Type
protein
Length
442 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xD0cfbEc245A8BAC2A6eE43DE22b2C650C2c695B5
Molecule
Terminal nucleotidyltransferase 5A
UniProt
Q96IP4
Pockets
2 · best druggability 0.74

Structure

1 distinct chain · 39% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATerminal nucleotidyltransferase 5Aprotein44239% helix, 14% strandQ96IP4

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18080.740.7957empty
21460.440.7621empty

Compared structures

  • 8EXF · Crystal structure of human FAM46A-BCCIPa complex at 3.2 angstrom resolution · an experimental structure of the same protein · chain A against A, TM-score 0.67

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.